Clinical trials
Observational Purpura, Thrombocytopenic, Idiopathic trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 4 |
| Unknown status | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Bordeaux | 3 |
| Centre Hospitalier Universitaire Dijon | 2 |
| University Hospital, Brest | 2 |
| University Hospital, Toulouse | 2 |
| Amgen | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| European Research Consortium on ITP | 1 |
| Henri Mondor University Hospital | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| Nantes University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Purpura, Thrombocytopenic, Idiopathic | 17 |
| Anemia, Hemolytic, Autoimmune | 3 |
| Arthritis, Juvenile | 1 |
| Autoimmune Diseases | 1 |
| Autoimmune Lymphoproliferative Syndrome | 1 |
| Diabetes Mellitus, Type 1 | 1 |
| Hepatitis, Autoimmune | 1 |
| Lupus Erythematosus, Systemic | 1 |
| Lymphohistiocytosis, Hemophagocytic | 1 |
| Neoplasms | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.